JP Morgan Chase & Co’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.05M | Buy |
|
|||||
|
2025
Q2 | $2.02M | Sell |
|
|||||
|
2025
Q1 | $4.33M | Sell |
|
|||||
|
2024
Q4 | $7.15M | Sell |
|
|||||
|
2024
Q3 | $7.75M | Buy |
|
|||||
|
2024
Q2 | $8.32M | Buy |
|
|||||
|
2024
Q1 | $10.8M | Buy |
|
|||||
|
2023
Q4 | $3.75M | Sell |
|
|||||
|
2023
Q3 | $7.3M | Buy |
|
|||||
|
2023
Q2 | $2.8M | Buy |
|
|||||
|
2023
Q1 | $2.06M | Buy |
|
|||||
|
2022
Q4 | $1.34M | Sell |
|
|||||
|
2022
Q3 | $1.93M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $910K | Sell |
|
|||||
|
2021
Q4 | $2.68M | Buy |
|
|||||
|
2021
Q3 | $727K | Buy |
|
|||||
|
2021
Q2 | $730K | Buy |
|